Insights on the
burden of
erosive
esophagitis
treatment

Real-world data on HCP and
patient treatment challenges

Hear from Dr Colin Howden

Learn about important takeaways from SOARD in erosive esophagitis:

  • Most physicians and patients are not completely satisfied with current treatment options
  • There is a need for new treatment options to heal erosions quickly, improve erosive esophagitis
    symptoms, and provide effective long-term healing
  • Both physicians and patients are interested in erosive esophagitis treatment options that are simpler
    to take

Most HCPs and patients reported that they were not fully satisfied with current treatment options

Only about half of HCPs believed that<br>patients’ treatment goals were<br>achievable with current treatments<sup>a</sup>

Only about half of HCPs believed
that patients’ treatment goals were
achievable with current treatmentsa


<b>Nearly 3 out of 5</b> of patients believed better control could be achieved<sup>b</sup>

Nearly 3 out of 5 of patients believed
better control could be achievedb

aIndicates percentages of physicians with a response of 6 or 7 on a 7-point scale that ranged from (1) completely disagree to (7) completely agree to the statement: “My erosive esophagitis patients’ treatment goals are achievable with current treatment options.” bIndicates percentages of patients with a response of “Satisfied, BUT I believe better control could be achieved” or “Not satisfied AND I believe better control could be achieved” to the question: “Which of the following statements best describes how satisfied you are with your current treatment for erosive esophagitis?”

HCPs want better initial healing and long-term maintenance

Only about half of HCPs believed that<br>patients’ treatment goals were<br>achievable with current treatments<sup>a</sup>

Nearly 5 out of every 10 reported that
faster initial healing would make them
believe that treatment would resolve the problemc


<b>Nearly 3 out of 5</b> of patients believed better control could be achieved<sup>b</sup>

More than half would have preferred a treatment option with better long-term maintenanced

cIndicates percentage of physicians with a response of 6 or 7 on a 7-point scale that ranged from (1) completely or strongly disagree to (7) completely or strongly agree to the statement “Faster healing makes me believe that treatment will resolve the problem.” dIndicates percentage of physicians with a response of 6 or 7 on a 7-point scale that ranged from (1) completely disagree to (7) completely agree to the statement: “I would prefer a treatment with better long-term maintenance rates than current options offer.”

Patients also desired better initial healing and
long-lasting results

Only about half of HCPs believed that<br>patients’ treatment goals were<br>achievable with current treatments<sup>a</sup>

7 out of 10 patients reported that
better initial healing would make
them feel hopeful that treatment
would resolve the probleme


<b>Nearly 3 out of 5</b> of patients believed better control could be achieved<sup>b</sup>

Most patients wanted long-lasting
treatment optionsf

eIndicates percentage of patients with a response of 6 or 7 on a 7-point scale that ranged from (1) strongly disagree to (7) strongly agree to the statement “Better initial healing of my esophagus makes me hopeful that the treatment will resolve the problem.” fIndicates percentage of patients with a response of 6 or 7 on a 7-point scale that ranged from (1) strongly disagree to (7) strongly agree to the statement: “I want whatever works for the longest.”

SOARD erosive esophagitis real-world evidence revealed that treatment challenges remain despite current therapeutic approaches

Patients and HCPs desired fast, effective, and long-lasting therapy

Almost 60% of patients
and HCPs saw fast
healing as importantg

What treatment challenges did patients and HCPs observe?

Patients
reported that current treatment options may not provide adequate control

Despite treatment,
almost
6 out of 10
patients continued
to
experience heartburn

of patients reported
that
they would adhere
to
proper dosing if it
worked
more quicklyh

HCPs
indicated that they would prefer treatments that are less of a burden

1 in 3 HCPs believed
patients
alter treatment
frequency
due to
treatment burden

of HCPs reported they
would prefer a product
that did not require
food-dependent dosingi

gIndicates percentage of responders with a response of 6 or 7 on a 7-point scale that ranged from (1) completely or strongly disagree to (7) completely or strongly agree to the statement “Fast healing is important to me” for patients and “Faster healing is important to me” for physicians.

hIndicates percentage of patients with a response of 6 or 7 on a 7-point scale that ranged from (1) strongly disagree to (7) strongly agree to the statement: “If a treatment works more quickly, I am more likely to take it as advised.”

iIndicates percentage of physicians with a response of 6 or 7 on a 7-point scale that ranged from (1) completely disagree to (7) completely agree to the statement: “I would prefer a product that didn’t have dosing requirements related to food.”

Discover real-world insights
from the SOARD publication

SOARD
Go to Publication

Get more insights on erosive
esophagitis from Dr Falk

SOARD
Watch Video

References:

  • 1.Howden CW, Spechler SJ, Vaezi MF, et al. Study of acid-related disorders: real-world physician and patient perspectives on burden of Helicobacter pylori infection. Gastro Hep Advances. 2022;1:231-240. doi: 10.1016/j.gastha.2021.12.005
  • 2.Vaezi MV, Brunton S, Fendrick AM, et al. Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients. BMJ Open Gastro. 2022;9:1-9. doi:10.1136/bmjgast-2022-000941

Register for information and updates